Tearney Lab at Wellman (MGH)

Until recently, visualizing the architectural and cellular morphology of human tissue has required histopathological examination. Samples would be excised from the patient, processed, sectioned, stained and viewed under a microscope. In addition to being invasive, time consuming and costly, the static nature of conventional pathology prohibits the study of biological dynamics and function. The Tearney Laboratory at Massachusetts General Hospital has led the way in transforming the current diagnostic paradigm through the invention and translation of new noninvasive, high-resolution optical imaging modalities that enable disease diagnosis from living patients without excising tissues from the body. Led by Guillermo (Gary) Tearney,...

Manufacturing engineering,optical engineering ,optical imaging ,coronary artery disease,barrett's esophagus,hirschsprung's disease,eosinophilic esophagitis,celiac disease,cystic fibrosis,micro optical coherence tomography (μoct),spectrally encoded endoscopy (see),optical frequency domain imaging (ofdi),spectrally encoded confocal microscopy (secm),photoacoustics,capsule technologies,biomedicine ,and clinical studies

Tearney lab at wellman (mgh) operates in the Biotechnology industry.

Tearney lab at wellman (mgh)'s revenue is 11m - 100m

Tearney lab at wellman (mgh) has 11 - 50 employees.